Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Pradel

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Microorganisms|September 28, 2021
Adherent-Invasive and Non-Invasive <i>Escherichia coli</i> Isolates Differ in Their Effects on <i>Caenorhabditis elegans'</i> LifespanMaria Beatriz de Sousa Figueiredo, Elizabeth Pradel, Fanny George, et al.
European Journal of Medicinal Chemistry|July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pumpNina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
Genome Biology and Evolution|July 30, 2014
Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogenAtsushi Iguchi, Yutaka Nagaya, Elizabeth Pradel, et al.
EMBO Molecular Medicine|January 4, 2024
Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniaeAnais Vieira Da Cruz, Juan-Carlos Jiménez-Castellanos, Clara Börnsen, et al.
Nature Communications|January 11, 2022
Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumpsColine Plé, Heng-Keat Tam, Anais Vieira Da Cruz, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Microorganisms|September 28, 2021
Adherent-Invasive and Non-Invasive <i>Escherichia coli</i> Isolates Differ in Their Effects on <i>Caenorhabditis elegans'</i> LifespanMaria Beatriz de Sousa Figueiredo, Elizabeth Pradel, Fanny George, et al.
European Journal of Medicinal Chemistry|July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pumpNina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
Genome Biology and Evolution|July 30, 2014
Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogenAtsushi Iguchi, Yutaka Nagaya, Elizabeth Pradel, et al.
EMBO Molecular Medicine|January 4, 2024
Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniaeAnais Vieira Da Cruz, Juan-Carlos Jiménez-Castellanos, Clara Börnsen, et al.
Nature Communications|January 11, 2022
Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumpsColine Plé, Heng-Keat Tam, Anais Vieira Da Cruz, et al.
Pageof 3